“We are pleased to have Steven join our outstanding team in the Brussels office,” said Bill DiGiacobbe, VP Business Development, Biomedical Systems. “He has a passion to educate sponsors on the innovative centralized diagnostic services Biomedical Systems has to offer for Cardiac Safety and Pulmonary Function.” In addition to providing Sponsors with a point of contact for proposals, RFIs, and CDAs, Mr. De Hertefelt will provide scientific, regulatory and inter-cultural expertise to the wide range of pharmaceutical, biopharmaceutical, and medical device companies as well as contract research organizations and clinical pharmacology units located in his territory. Mr. De Hertefelt has a Masters in Translation and a Masters in Interpreting for English-Dutch-Spanish from Erasmushogeschool Brussel - Department Applied Linguistics. Mr. De Hertefelt, who also speaks fluent French, will work from Biomedical Systems’ Brussels, Belgium office.
About Biomedical Systems
Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical and medical device industries. With offices in North America, Europe and Asia, Biomedical Systems has worked with over 14,000 investigative sites in 78 countries around the world for Phase I - IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Cardiac, Imaging, Pulmonary, EEG and Digital Pathology modalities used to determine safety and efficacy for drugs and devices in clinical trials.
For more information on Biomedical Systems please contact Craig Pennington at cpennington@biomedsys.com or go to the company website www.biomedsys.com.
